Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 38, Issue 3, 2009, Pages 307-313

  Zhang, Mingbin ^a,b   Zhang, Ping ^a   Zhang, Chenping ^a   Sun, Jian ^a   Wang, Lizhen ^a   Li, Jiang ^a   Tian, Zhen ^a   Chen, Wantao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TAIAN CENTRAL HOSPITAL   (China)

Author keywords

Apoptosis; Bax; Bcl 2; Biomarker; Oral squmaous cell carcinoma; Prognosis

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 61349141974     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00689.x     Document Type: Article

References (44)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1999. CA Cancer. J Clin 1999 49 : 8 31.
2. Katsanaki KD, Owen C, Zoumpourlis V. JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascade means to understand their in vivo biological role. Anticancer Res 2002 22 : 755 9.
3. Schmandt R, Mills GB. Genomic components of carcinogenesis. Clin Chem 1993 39 : 2375 85.
4. Cheng EH, Kirsch DG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997 278 : 1966 8.
5. Harada H, Becknell B, Wilm M, et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Molecular Cell 1999 2 : 413 22.
6. Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000 288 : 1053 8.
7. Jordan RC, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol 1996 32 : 394 400.
8. Chrysomalie E, Greenspan JS, Dekker N, Greenspan D, Regzi JA. Apoptosis associated proteins in oral hairy leukoplakia. Oral Dis 1996 2 : 279 84.
9. Soini Y, Tormaneu U, Paakko P. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumors. Histopathology 1998 32 : 28 34.
10. Andrews N, Helliwell T, Walker C, Jones AS. Differing expression of bax and bcl-2 may influence the different cure rates in mouth and orophayrngeal cancer. Clin Otolaryngol Allied SCI 2000 25 : 570 6.
11. Ravi D, Nalinakumari KR, Rajaram RS, Nair MK, Pillai MR. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett 1996 105 : 139 46.
12. Loro LL, Johannessen AC, Vintermyr OK. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations. J Clin Pathol 2005 58 : 1157 62.
13. Papadopoulos K. Targeting the Bcl-2 family in cancer therapy. Semin Oncol 2006 33 : 449 56.
14. Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M, Syrjanen K. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favorable prognosis. J Pathol 1995 177 : 49 55.
15. Ohbu M, Saegusa M, Kobayashi N, et al. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 1997 79 : 1287 93.
16. Ghanem MA, Van Der Kwast TH, Den Hollander JC, et al. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Br J Cancer 2001 85 : 1557 63.
17. Keshgegian AA, Johnston E, Cnaan A. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. Am J Clin Pathol 1998 110 : 443 9.
18. Teni T, Pawar S, Sanghvi V, Saranath D. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res 2002 8 : 109 14.
19. De Vicente JC, Olay S, Lequerica-Fernandez P, Sanchez-Mayoral J, Junquera LM, Fresno MF. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 2006 35 : 140 5.
20. Friedman M, Grey P, Venkatesan TK, et al. Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 1997 106 : 445 50.
21. Gallo O, Bianchi S. Bcl-2 overexpression and smoking history in head and neck cancer. J Natl Cancer Inst 1995 87 : 1024 5.
22. Costa A, Licitra L, Veneroni S, et al. Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. Int J Cancer 1998 79 : 619 23.
23. Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999 86 : 913 20.
24. Wilson GD, Grover R, Richman PI, et al. Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 1996 6 : 2403 8.
25. Staibano S, Mignona MD, Lo Muzio L, et al. Overexpression of cyclin D1, bcl-2 and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 1998 29 : 1189 94.
26. Singh BB, Chandler FW, Whitaker SB, et al. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 85 : 692 8.
27. Friess H, Lu Z, Graber HU, et al. Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 1998 43 : 414 21.
28. Georgiou A, Gomatos IP, Ferekidis E, et al. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Eur J Surg Onco 2001 27 : 574 80.
29. Lo Muzio L, Mignogna MD, Pannone G, et al. Expression of blc-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinic-pathological correlations. Oncol Rep 2003 10 : 285 91.
30. Schoelch ML, Le QT, Silverman S Jr., et al. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999 35 : 77 85.
31. Ito T, Fujieda S, Tsuzuki H, et al. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett 1999 140 : 81 91.
32. Sturm I, Petrowsky H, Volz R, et al. Analysis of p53/BAX/p16 (ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16 (ink4a/CDKN2) identifies patients with good prognosis. J Clin Oncol 2001 19 : 2272 81.
33. Paulino AF, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope 2000 110 : 1479 82.
34. Baltaziak M, Duraj E, Koda M, et al. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma. Ann N Y Acad Sci 2006 1090 : 18 25.
35. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998 281 : 1322 6.
36. Gross A, Mcdonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999 13 : 1899 911.
37. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993 74 : 609 19.
38. Reed JC. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 1995 9 : 451 73.
39. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995 11 : 101 5.
40. Boman AL, Delannoy MR, Wilson KL. GTP hydrolysis is required for vesicle fusion during nuclear envelope assembly in vitro. J Cell Biol 1992 144 : 281 92.
41. Crowson AN, Magro CM, Kadin ME, Stranc M. Differential expression of the bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 1996 27 : 355 9.
42. Derka S, Vairaktaris E, Papakosta V, et al. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 2006 42 : 540 50.
43. Marx D, Binder C, Meden H, et al. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer. Anticancer Res 1997 17 : 2233 40.
44. Poeta GD, Venditti A, Del Principe MI, et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcomein acute myeloid leukemia (AML). Blood 2003 101 : 2125 31.